NEPHROGENEX INC - 640667101
Sector:
No information yet
· Industry:
No information yet
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q2 2014
· Q1 2014
Value (USD)
Total reported value ($000)
$14.97M
QoQ value delta ($000)
-$3.089M
(-17.11%)
Implied price effect (QoQ)
-17.16%
Shares
Total shares
2,218,280
QoQ shares delta
+1,426
(+0.06%)
Total shares held by funds (by quarter)
Top holders (Q2 2014)
Top 25 only
Full list
Partial Q2 2014 data: 5 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 8,067 | 1,326,826 | 3.13% |
| Visium Asset Management, LP | 3,932 | 476,491 | 0.06% |
| LMR Partners LLP | 886 | 147,250 | 0.07% |
| Revelation Capital Management Ltd. | 792 | 97,607 | 6.06% |
| Knoll Capital Management, LP | 412 | 50,000 | 0.21% |
| BANK OF AMERICA CORP /DE/ | 319 | 39,300 | 0.0% |
| First Western Capital Management Co | 171 | 28,083 | 0.06% |
| FIRST NEW YORK SECURITIES LLC /NY | 159 | 19,550 | 0.08% |
| STONERIDGE INVESTMENT PARTNERS LLC | 116 | 19,125 | 0.02% |
| Trellus Management Company, LLC | 81 | 10,000 | 0.07% |
| Tower Research Capital LLC | 18 | 2,255 | 0.0% |
| MORGAN STANLEY | 7 | 815 | 0.0% |
| BlackRock Investment Management, LLC | 3 | 568 | 0.0% |
| UBS AG | 2 | 236 | 0.0% |
| CITIGROUP INC | 1 | 174 | 0.0% |